Skip to main content
. 2021 Oct 16;13(20):5189. doi: 10.3390/cancers13205189
APC antigen-presenting cell
BART BamHI fragment A rightward transcript
BHRF1 BamHI fragment H rightward transcript 1
BL Burkitt lymphoma
CAF cancer-associated fibroblast
cHL classical Hodgkin lymphoma
CAR chimeric antigen receptor
CR2 complement C3d receptor 2
DC dendritic cell
DCBCL diffuse large B-cell lymphoma
DNMT DNA methyltransferase
ECM extracellular matrix
EBER EBV-encoded small RNA
EBNA EBV nuclear antigen
EBV Epstein–Barr virus
EV extracellular vesicle
FFPE formalin-fixed and paraffin-embedded
GC gastric carcinoma
gp glycoprotein
gran granzyme
HHV human herpes virus
HL Hodgkin lymphoma
HLA human leukocyte antigen
HNSCC head and neck squamous cell carcinoma
HPV human papilloma virus
HRS Hodgkin–Reed/Sternberg
IC immune cell
IDO indolamine 2, 3-deoxygenase
IFN interferon
IHC immunohistochemistry
IL interleukin
IP-10 interferon-mediated protein P
IRF interferon-regulatory factor
ISG interferon-stimulatory gene
ISH in situ hybridization
LMP latent membrane protein
MDSC myeloid-derived suppressor cell
MHC major histocompatibility complex
miRNA microRNA
NK natural killer
NOS not otherwise specified
NPC nasopharyngeal carcinoma
PBMC peripheral blood mononuclear cell
PCR polymerase chain reaction
PD1 programmed death receptor-1
PD-L1 programmed death ligand-1
PTLD post-transplant lymphoproliferative disorder
PBMC peripheral blood mononuclear cell
PCR polymerase chain reaction
ROS reactive oxygen species
TAM tumor-associated macrophage
TAP transporter associated with antigen processing
TIL tumor-infiltrating lymphocyte
TLR toll-like receptor
TME tumor microenvironment
TNF tumor necrosis factor
Treg regulatory T cell
UTR untranslated region
VCA viral capsid antigen
vIL-10 viral interleukin-10